Berberine forms and barberry: how to compare them
Which berberine forms were studied, how regimens differ, and why barberry berries are not equivalent to a tablet dose.
Key points
- Studies used different berberine forms and regimens. Compare the form name, amount and study goal: the same substance name does not make regimens interchangeable. [1] [2] [3] [4] See the evidence 1
- Barberry berries contain varying amounts of berberine depending on the raw material and processing. A serving of berries or a dish cannot be equated with a tablet dose. [5] [6] [7] See the evidence 1
- Berberine should be avoided during pregnancy and breastfeeding; it is not given to infants. When choosing a supplement, also consider medicines and health conditions. [8] [9] [10] [11] [1] See the evidence 1
Practical guide
Check the conclusions and whether they apply to your situation.
Berberine occurs in different products and research forms. The specific form, amount and purpose matter when comparing them.
Key points
Why these conclusions
Forms, regimens and edible barberry
Berberine hydrochloride is a salt form. For IBS with diarrhoea, 200 mg twice daily was studied for eight weeks; for obesity, 500 mg twice daily after breakfast and dinner was studied for six months. In the second study, each dose consisted of five 100 mg tablets. These are different groups and research regimens. [1] [2] [3] [4]
Other studies used berberine tablets or capsules without specifying the exact salt. These studies did not compare forms in a way that identifies the best form for every purpose. [1] [2] [3] [4]
Common barberry berries are used as food. Berberine content depends on the raw material and processing; berry dishes are not equivalent to the studied tablet dose. [5] [6] [7]
Information from the source
| Name | Description | Sources |
|---|---|---|
| Berberine hydrochloride | This is a salt form of berberine. In the IBS with diarrhoea trial, 200 mg twice daily was used for eight weeks; in obesity, 500 mg twice daily after breakfast and dinner was used for six months. In the second study, each dose consisted of five 100 mg tablets. The same substance name does not make these regimens interchangeable. | [1] [2] |
| Tablets and capsules in other trials | For elevated blood sugar, berberine tablets at 500 mg twice daily were studied for 16 weeks; in a running experiment, 750 mg capsules twice daily were studied for seven days. The exact salt form was not specified in these articles. These trials do not provide a comparison that identifies the best form for all purposes. | [3] [4] |
Information from the source
Berries of common barberry (Berberis vulgaris) are used as food. The amount of berberine in a serving depends on the raw material and processing; berries and dishes made from them are not equivalent to a tablet dose. Ornamental barberry species are not included in this food list. [5] [6] [7]
Information from the source
Berberine may cause abdominal pain or discomfort, nausea, vomiting, constipation and diarrhoea. Berberine should be avoided during pregnancy and breastfeeding; it is not given to infants. It may contribute to dangerous bilirubin accumulation in an infant, with brain damage. The French agency ANSES also recommends that children and adolescents and people with diabetes, liver disease or heart disease avoid berberine supplements. Severe heart-rhythm disturbances with QT interval prolongation on an ECG have been reported after berberine use. In one case, large doses of cannabinoid oil were taken at the same time; in another, arrhythmia occurred in an older man taking 500 mg berberine daily. Case reports do not show how often this happens, but fainting or pronounced palpitations require urgent medical assessment. In the six-month BRAVO trial, serious adverse events were recorded in 6 of 169 participants with berberine and 2 of 168 with placebo; the difference was not statistically significant. These events are not equivalent to proven adverse effects of berberine. Before the main part of the study, people who could not tolerate the run-in were excluded. [8] [9] [10] [11] [1]
Sources
- Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial. https://pubmed.ncbi.nlm.nih.gov/41543854/
- A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. https://pubmed.ncbi.nlm.nih.gov/26400188/
- Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study. https://pubmed.ncbi.nlm.nih.gov/34365978/
- Dietary berberine supplementation improves select physiological and psychological responses during exertional heat stress: A pilot study in young adults. https://pubmed.ncbi.nlm.nih.gov/42204774/
- The analysis of berberine content in the fruits of various species of barberry (Berberis sp.) by high performance thin-layer chromatography (HPTLC). https://www.czytelniamedyczna.pl/7459,analiza-zawartosci-berberyny-w-owocach-roznych-gatunkow-berberysu-berberis-sp-me.html
- Effect of extraction conditions on antioxidant activity of barberry (Berberis vulgaris L.) fruit extracts. https://pubmed.ncbi.nlm.nih.gov/30713616/
- Development of an Optimized Drying Process for the Recovery of Bioactive Compounds from the Autumn Fruits of Berberis vulgaris L. and Crataegus monogyna Jacq. https://pmc.ncbi.nlm.nih.gov/articles/PMC8533465/
- In the News: Berberine. https://www.nccih.nih.gov/health/in-the-news-berberine
- ANSES Opinion on the safety of use of berberine-containing plants in the composition of food supplements — Request 2018-SA-0095. https://www.anses.fr/system/files/NUT2018SA0095EN.pdf
- Harmless herbs? A case report of acquired long QT syndrome and torsades de pointes in a patient taking herbal supplements. https://pmc.ncbi.nlm.nih.gov/articles/PMC9123311/
- Berberine Poisoning with Polymorphic Ventricular Tachycardia: A Case Report. https://pmc.ncbi.nlm.nih.gov/articles/PMC13517994/
Methodology: Subpages evidence-led supplement pipeline v1